4th Quarter - Report — BIOCOM for BIOCOM (2014)

Firm

BIOCOM

Client

BIOCOM

Income

—

Expenses

$32,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Asked to reauthorize the tax extenders. Asked to repeal the medical device tax.

Lobbyist	Covered position, as disclosed
LAURE FABREGA CLARK	—

Contacted: SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Health Issues HCR

Discussed 21st Century Cures proposals. Organized a Fly-In to discuss the digital health landscape, including regulation, reimbursement, data privacy and ownership, electronic health records (EHRs) and patient-generated health data (PGHD).

Lobbyist	Covered position, as disclosed
LAURE FABREGA CLARK	—

Contacted: Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

Asked for increased funding for NIH, FDA, and biorenewable programs.

Lobbyist	Covered position, as disclosed
LAURE FABREGA CLARK	—

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.